3,4-DAA has anti-inflammatory activity, ameliorates acute hepatic allograft injury, and alleviates severe acute pancreatitis by inhibiting intestinal barrier dysfunction and NF-kappaB activation.3,4-DAA inhibits EOC20 cell-inducible nitric oxide synthase (iNOS) induced by IFN-gamma and lipopolysaccharide.
Molekulargewicht:
343.33
CAS Nummer:
[2117759-07-4]
Formel:
C18H17NO6
Target-Kategorie:
NOS
T22506
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten